Guaifenesin Solution
FDA Label NDC 55154-5780

13 label sections · Submitted to the FDA by Cardinal Health 107, Llc · Indications, Dosage, Usage, and Precautions

Structured Product Label

The following Structured Product Label (SPL) was submitted to the FDA by Cardinal Health 107, Llc for the product Guaifenesin (NDC 55154-5780). This document serves as the official prescribing information, containing essential scientific data and clinical materials required for healthcare providers and patients.

This specific version of the label includes detailed information regarding otc - purpose, description, inactive ingredients, uses, ask a doctor before use if you have, stop use and ask a doctor if, otc - pregnancy or breast feeding, otc - keep out of reach of children, and other regulatory disclosures. Use the navigation below to review specific sections of the FDA submission.

Principal Display Panel

NDC 55154-9450-5

GUAIFENESIN ORAL SOLUTION USP

100 mg/5mL

5 CUPS

100mg/5ml Bag Label (365011d4 Ff31 423f A6f1 D1e2fd402c5d 00)

100mg/5ml Bag Label (365011d4 Ff31 423f A6f1 D1e2fd402c5d 00)

NDC 55154-5780-5

GUAIFENESIN ORAL SOLUTION USP

200 mg/10 mL

5 CUPS

200mg/10ml Bag Label (25a970c7 0016 4f22 9e94 1e20e1319e3e 00)

200mg/10ml Bag Label (25a970c7 0016 4f22 9e94 1e20e1319e3e 00)

* Please review the disclaimer below.